Sectors
FLNA
Filana Therapeutics, Inc.
0.97
1 x 0.95
1 x 1.02
bid
ask
-
0.03
2.58%
1 @ 04:00 PM
0.97 -0.00 (0.16%)
| Ytd | -50.93% | |
| 1y | -56.82% |
0.96
day range
1.03
0.86
52 week range
4.98
| Open | 1.01 | Prev Close | 1.00 | Low | 0.96 | High | 1.03 | Mkt Cap | 46.94M |
| Vol | 271.80K | Avg Vol | 364.53K | EPS | -0.47 | P/E | -2.07 | Forward P/E | N/A |
| Beta | -0.70 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 1.16 | 200-d Avg | 1.94 | 1yr Est | 0.00 |
FLNA News
globenewswire.com
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
AUSTIN, Texas, July 29, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Th
globenewswire.com
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana The
globenewswire.com
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
AUSTIN, Texas, May 05, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana The
defenseworld.net
Zevra Therapeutics (NASDAQ:ZVRA) versus Cassava Sciences (NASDAQ:FLNA) Head-To-Head Contrast
Zevra Therapeutics (NASDAQ: ZVRA - Get Free Report) and Cassava Sciences (NASDAQ: FLNA - Get Free Re